The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 08, 2025
Filed:
Feb. 24, 2021
Applicant:
Theaprin Pharmaceuticals, Inc., Hauppauge, NJ (US);
Inventors:
Harry G. Brittain, Milford, NJ (US);
Philip V. Felice, Smithtown, NY (US);
Assignee:
THEAPRIN PHARMACEUTICALS, INC., Hauppauge, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/192 (2006.01); A61K 9/14 (2006.01); A61K 31/13 (2006.01); A61K 31/137 (2006.01); A61K 31/198 (2006.01); A61K 31/277 (2006.01); A61K 31/34 (2006.01); A61K 31/4045 (2006.01); A61K 31/4164 (2006.01); A61K 31/4196 (2006.01); A61K 31/426 (2006.01); A61K 31/43 (2006.01); A61K 31/431 (2006.01); A61K 31/445 (2006.01); A61K 31/4453 (2006.01); A61K 31/4709 (2006.01); A61K 31/4745 (2006.01); A61K 31/48 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/522 (2006.01); A61K 31/536 (2006.01); A61K 31/545 (2006.01); A61K 31/546 (2006.01); A61K 31/549 (2006.01); A61K 31/573 (2006.01); A61K 31/603 (2006.01); A61K 31/635 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/7072 (2006.01); A61K 38/12 (2006.01); A61K 47/26 (2006.01); A61P 31/00 (2006.01); C07C 57/30 (2006.01); C07C 59/105 (2006.01); C07C 69/157 (2006.01); C07C 211/38 (2006.01); C07C 215/58 (2006.01); C07C 229/36 (2006.01); C07C 255/41 (2006.01); C07D 209/14 (2006.01); C07D 209/24 (2006.01); C07D 211/22 (2006.01); C07D 215/22 (2006.01); C07D 233/94 (2006.01); C07D 249/08 (2006.01); C07D 261/16 (2006.01); C07D 265/18 (2006.01); C07D 277/56 (2006.01); C07D 285/28 (2006.01); C07D 307/52 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 457/04 (2006.01); C07D 457/06 (2006.01); C07D 473/18 (2006.01); C07D 473/30 (2006.01); C07D 491/22 (2006.01); C07D 499/00 (2006.01); C07D 499/24 (2006.01); C07D 501/22 (2006.01); C07D 519/00 (2006.01); C07D 519/02 (2006.01); C07H 15/252 (2006.01); C07H 17/08 (2006.01); C07H 19/06 (2006.01); C07K 7/08 (2006.01); C07J 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/145 (2013.01); A61K 31/13 (2013.01); A61K 31/137 (2013.01); A61K 31/192 (2013.01); A61K 31/198 (2013.01); A61K 31/277 (2013.01); A61K 31/34 (2013.01); A61K 31/4045 (2013.01); A61K 31/4164 (2013.01); A61K 31/4196 (2013.01); A61K 31/426 (2013.01); A61K 31/43 (2013.01); A61K 31/431 (2013.01); A61K 31/445 (2013.01); A61K 31/4453 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 31/48 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/522 (2013.01); A61K 31/536 (2013.01); A61K 31/545 (2013.01); A61K 31/546 (2013.01); A61K 31/549 (2013.01); A61K 31/573 (2013.01); A61K 31/603 (2013.01); A61K 31/635 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7072 (2013.01); A61K 38/12 (2013.01); A61K 47/26 (2013.01); A61P 31/00 (2018.01); C07C 57/30 (2013.01); C07C 59/105 (2013.01); C07C 69/157 (2013.01); C07C 211/38 (2013.01); C07C 215/58 (2013.01); C07C 229/36 (2013.01); C07C 255/41 (2013.01); C07D 209/14 (2013.01); C07D 209/24 (2013.01); C07D 211/22 (2013.01); C07D 215/22 (2013.01); C07D 233/94 (2013.01); C07D 249/08 (2013.01); C07D 261/16 (2013.01); C07D 265/18 (2013.01); C07D 277/56 (2013.01); C07D 285/28 (2013.01); C07D 307/52 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 457/04 (2013.01); C07D 457/06 (2013.01); C07D 473/18 (2013.01); C07D 473/30 (2013.01); C07D 491/22 (2013.01); C07D 499/00 (2013.01); C07D 499/24 (2013.01); C07D 501/22 (2013.01); C07D 519/00 (2013.01); C07D 519/02 (2013.01); C07H 15/252 (2013.01); C07H 17/08 (2013.01); C07H 19/06 (2013.01); C07K 7/08 (2013.01); A61K 2300/00 (2013.01); C07B 2200/13 (2013.01); C07C 2603/74 (2017.05); C07J 5/0053 (2013.01); Y02A 50/30 (2018.01);
Abstract
A platform drug delivery system and a method of improving the delivery of low solubility pharmaceuticals utilizing crystal engineering and Theanine dissolution resulting in enhanced bioactivity, dissolution rate, and solid state stability.